2018
DOI: 10.1007/s40140-018-0264-7
|View full text |Cite
|
Sign up to set email alerts
|

Mivacurium: a Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…28 Mivacurium is a short-acting, non-depolarizing neuromuscular blocker (NMB) that is utilized as an aide to general anesthesia to permit endotracheal intubation. 29 It has a short duration of action ranging from 10 to 15 min in normal patients, because it undergoes rapid metabolism and deactivation via hydrolysis of its ester linkage by plasma cholinesterase enzyme (PChE). 30 Although it is well-established that mivacurium has a limited duration of action that allows patients to recover rapidly after the surgery and begin to breath normally, many reported cases have suffered from a prolonged action reaching up to 16 h. 31,32 It was found -after various investigations-that those people (poor metabolizers) have either genetically or acquired deficiency in PChE which is solely responsible for mivacurium metabolism.…”
mentioning
confidence: 99%
“…28 Mivacurium is a short-acting, non-depolarizing neuromuscular blocker (NMB) that is utilized as an aide to general anesthesia to permit endotracheal intubation. 29 It has a short duration of action ranging from 10 to 15 min in normal patients, because it undergoes rapid metabolism and deactivation via hydrolysis of its ester linkage by plasma cholinesterase enzyme (PChE). 30 Although it is well-established that mivacurium has a limited duration of action that allows patients to recover rapidly after the surgery and begin to breath normally, many reported cases have suffered from a prolonged action reaching up to 16 h. 31,32 It was found -after various investigations-that those people (poor metabolizers) have either genetically or acquired deficiency in PChE which is solely responsible for mivacurium metabolism.…”
mentioning
confidence: 99%